Register Now

Home      Flyer      Curriculum      Faculty      Benefits      Schedule     FAQ

  This ECHO provides training in opioid addiction treatment at no cost, delivered right to your clinic, with a variety of bi-weekly schedules to choose from. We serve federally-qualified health centers, with a special focus on those that received the Substance Abuse Service Expansion awards. Using simple videoconferencing technology, healthcare teams connect to a community of learners which offers:
  • Free continuing education credit
  • Opportunity to present actual patient cases, in a de-identified format, and receive specialty input
  • Addiction treatment training, including management of naloxone/buprenorphine (e.g. Suboxone) and injectable naltrexone (e.g. Vivitrol)
  • Access to a virtual learning community for access to treatment guidelines, tools, and patient resources
  • Certificate of training completion from ECHO and the American Society of Addiction Medicine
Opioid Addiction Treatment ECHO focuses on providers and primary care team members.   Learn more about the Opioid Addiction Treatment ECHO
Join us for an Introduction Session on Project ECHO’s Opioid Addiction Treatment Program targeted for HRSA-funded health centers 23 June 2017, 9:30- 10:30 MT. For more information contact opioidecho@salud.unm.edu.  Add Calendar Icon
  How to connect:  To connect to this introductory session, click here:  https://echo.zoom.us/j/7187244318.  After entering the password 834795, you’ll be connected by video-conference to the session. If you don’t yet have Zoom on your device, when you click the link, you’ll be prompted to install Zoom (free of charge). Sign in a little early to make sure that your audio and video are working. If you have any technical difficulties, call 505-750-4897 for support    

Click here to register for this no-cost Program.

Home      Flyer      Curriculum      Faculty      Benefits      Schedule     FAQ

Contact us: 505-925-2406                      OpioidECHO@salud.unm.edu

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government